SG Analytics (SGA) uses AI/ML algorithms to provide exact answers when assessing the value of a new treatment or product for reimbursements and healthcare payers.
Daily and favorable health outcomes are analyzed through health economics and outcomes research (HEOR) studies of healthcare providers, clinics, hospitals, managed care, and community health promotion initiatives in various settings.
In 2020, SG Analytics first offered health economics and outcomes research services and solutions. Our pharmaceutical clients consistently rank this service among our most in-demand options. Using machine learning technologies, our health economics and outcomes research experts can scrape accurate real-world data relevant to medical research and disease... Read More
With each passing day, HEOR gains more and more importance because it aids in the best allocation of healthcare resources by providing vital information to decision-makers in the pharmaceutical, diagnostic, and medical product industries, empowering healthcare professionals and consumers. Suppose a pharmaceutical or biomedical firm wants to get reimbursed in the future for a new treatment, diagnostic kit, product, or other intervention. In that case, they must research health economics outcomes to support their strategy and marketing teams. HEOR reports cost millions of dollars and are notoriously time-consuming and difficult to get.
Why SGA
Industry Leaders
SGA thrives by its brand promise Lifes Possible and is recognized as the trusted life sciences & healthcare business consulting and services provider company in the U.S.
12+ Languages
Multilingual capabilities include Mandarin, Cantonese, Korean, German, Spanish, Arabic, Bahasa, Hindi, Bengali, and English (U.S. & U.K.) experts (either in-house or partnerships).
Data-Driven Insights
With in-depth domain knowledge and proven capabilities of delivering monetizable insights, we deliver high-quality, efficient outputs.
End-To-End Solutioning
The in-house KOL capability of more than 700, along with in-house capabilities of primary market research, financial research, data analytics, engineering, IT, and ESG research and consulting, helps to present credible competitive information.
White Papers
Emergence of Novel Immune - Mediated Therapies
Immunotherapy has emerged as a promising treatment for cancer, with immune checkpoint inhibitors (ICIs) dominating the market. The market is projected to...
White Papers
Future Trends and Technological Advances in Vaccine and...
The introduction of vaccines for key diseases, such as meningococcal meningitis A, hepatitis E, and malaria, in recent years has helped to reduce mortality...
CASE STUDIES
We strongly believe in equal opportunity for all. Our research team consists of more females than males i.e., 55 % females, and consists of PhDs, M Pharms, D Pharms, Postgraduate in finance, Biotech postgraduates, and MBAs.
